Cancer Home > Altretamine

Important Information for Your Healthcare Provider

Talk with your healthcare provider prior to taking this medication if you have:
 
  • Kidney disease, such as kidney failure (renal failure)
  • Liver disease, such as hepatitis, cirrhosis, or liver failure
  • Had severe bone marrow depression (very low red blood cells, white blood cells, or platelets)
  • Nerve damage or a disorder of the nervous system (the brain and nerves)
  • Ever had a seizure
  • Any allergies, including to foods, dyes, or preservatives.
 
Also, let your healthcare provider know if you are:
   
Make sure to tell your healthcare provider about all other medications you are taking, including prescription and nonprescription medicines, vitamins, and herbal supplements.
 
(Click Precautions and Warnings With Altretamine to learn more, including information on who should not take the drug.)
 

Clinical Effects of Altretamine

In clinical studies, altretamine was given to women with ovarian cancer who had previously been treated with chemotherapy medicine combinations, including cisplatin (Platinol®) or medicines in the same class as altretamine (other alkylating agents). In these studies, 18 percent of women had either a complete or partial response to altretamine. The response lasted anywhere from 2 months to 36 months.
 
Written by/reviewed by:
Last reviewed by: Kristi Monson, PharmD;
Last updated/reviewed:
List of references (click here):
Other Articles in This eMedTV Presentation
Advertisement


Topics

Medications

Quicklinks

Related Channels

eMedTV Links
Copyright © 2006-2019 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.